The Sundyota Numandis Group, on Wednesday, announced a strategic alliance with Finzelberg, Germany, to offer novel, natural healthcare products in India.
To start with, Sundyota Numandis will introduce 'ERr73', a product complimenting women’s health during menopause and peri-menopause, for the first time in India.
Sundyota Numandis is a global health-oriented organization focused on providing safe healthcare products and clinically proven therapies from non-synthetic sources.
Finzelberg is a business unit of the Martin Bauer Group (Germany), manufacturing phyto-pharmaceuticals and phyto-nutraceuticals. The Martin Bauer Group is a supplier of herbal and fruit infusions, medicinal teas, flavored black and green teas, aromas, herbal powders, botanicals, herbal, fruit and tea extracts.
As part of the pact, Sundyota Numandis will procure active ingredients from Finzelberg, undertake their formulation and development and seek registration and regulatory approvals of the same. This will be followed by commercial manufacturing along with product launch, marketing and co-marketing through promotion to doctors and pharmaceutical companies in India, said Dinesh Kumar Arora, Managing Director-CEO, here.
The new product unveiled here aims to ease over 20 symptoms related to menopause and peri-menopause, thus acting as a natural female hormone. Being devoid of any side effects over long term use, it has a safety profile.
“We now have 12 international alliances to foster healthcare the natural way along with over 60 patented therapies. ERr731 is safer than any currently available therapy for menopause. It facilitates a smooth transition for women experiencing menopause”, he said.
Dr. Rene Roth-Ehrang, Member of the Management Board, Sales & Marketing, said Finzelberg is a family-owned extract manufacturer since 1875.
Some innovation-driven products on the anvil are natural anti-microbial cure for upper respiratory tract infections, a cough syrup that promises zero side-effects, and a dedicated product for heavy and fatigued legs caused due to chronic venous insufficiency.
Dr. Rainer Kunz, Area Sales Manager, Europe, Middle East & India said more projects will follow providing modern phyto-pharmaceutical solutions for today’s lifestyle.
Sundyota Numandis has been listed among the top 50 of India’s Most Promising Brands 2016, compiled by the World Consulting & Research Corporation.
Finzelberg produces more than 800 products for global customers using methods to extract the natural healing powers of leaves, flowers, barks, roots, seeds and fruits.